Eccrine Sweat Glands: Development, Structure, and Thermoregulation

The eccrine sweat gland is among the most ancient and essential of human skin appendages. Unlike the hair follicle—which cycles through growth and rest—or the sebaceous gland—which releases its contents through cellular destruction—the eccrine gland functions as a true exocrine organ, secreting a watery fluid through merocrine mechanisms to cool the body surface. Humans possess between 1.5 and 4 million eccrine glands distributed across nearly all body surfaces, with the highest density on the palms and soles where tactile sensitivity and grip depend upon finely tuned moisture. This section examines the embryology, anatomy, physiology, and clinical relevance of the eccrine gland.

Embryological Origins

Eccrine sweat glands develop from the surface ectoderm independently of the pilosebaceous unit. At approximately 3 months' gestation, solid cords of epithelial cells begin to descend from the epidermal ridges of the palmoplantar surfaces—the sites where eccrine glands are most numerous and most vital for fine motor function. By 5 months' gestation, similar epithelial downgrowths have appeared across the remainder of the body, excluding only the vermilion lips, glans penis, clitoris, labia minora, and external auditory canals.

The developmental independence of the eccrine gland from the pilosebaceous follicle is clinically significant. While apocrine glands drain into hair follicles and share developmental signaling pathways with sebaceous glands, eccrine glands open directly onto the epidermal surface and are regulated by distinct transcriptional programs. This explains why ectodermal dysplasias affecting hair and sebaceous glands may spare eccrine function, whereas hypohidrotic ectodermal dysplasia (HED)—caused by mutations in the EDA/EDAR/EDARADD pathway—disrupts eccrine gland formation while also affecting hair and teeth.

Functional eccrine glands are present at birth and respond immediately to thermal and emotional stimuli. This stands in contrast to apocrine glands, which remain quiescent until activated by pubertal androgens.

Anatomy of the Eccrine Gland

Secretory Coil

The eccrine gland consists of two anatomically and functionally distinct components: a secretory coil located in the deep dermis or subcutaneous fat, and a dermal and epidermal duct that transports sweat to the skin surface. The secretory coil is tightly convoluted—a design that maximizes secretory surface area within a limited volume of tissue.

The epithelium of the secretory coil contains three cell types arranged in a single layer:

Clear cells are the primary secretory cells of the eccrine gland. These large, polygonal cells with pale cytoplasm are responsible for the active transport of electrolytes and the osmotic movement of water into the glandular lumen. They express aquaporin-5 (AQP5) on their apical membranes, facilitating rapid water flux in response to cholinergic stimulation. Clear cells also produce dermcidin, an antimicrobial peptide unique to eccrine sweat that provides innate immune defense against surface pathogens.

Dark cells are smaller, pyramidal cells with basophilic cytoplasm containing secretory granules rich in sialomucin. Their precise function remains incompletely understood, but they are thought to contribute glycoprotein components to the primary secretion. Dark cells may also serve a structural role in maintaining the integrity of the glandular epithelium.

Myoepithelial cells ensheath the secretory coil between the basement membrane and the secretory epithelium. These contractile cells contain abundant smooth muscle actin and, upon stimulation, compress the glandular lumen to propel sweat toward the ductal system. Myoepithelial cells are innervated by sympathetic cholinergic fibers and respond to the same neural signals that stimulate secretion.

Eccrine Duct

The eccrine duct is a two-layered tube of cuboidal cells that extends from the secretory coil through the dermis and epidermis to the skin surface. Unlike the secretory coil, the ductal epithelium lacks myoepithelial cells. The duct serves not merely as a passive conduit but as an active modifier of sweat composition.

Within the dermal duct, the inner luminal cells contain abundant mitochondria and express the epithelial sodium channel (ENaC) on their apical surfaces. This channel reabsorbs sodium and chloride from the primary sweat as it traverses the duct, converting an initially isotonic secretion into the hypotonic sweat that reaches the skin surface. The efficiency of this reabsorption determines the final electrolyte concentration of sweat—a principle exploited in the sweat chloride test for cystic fibrosis, where defective CFTR function impairs chloride reabsorption and produces abnormally salty sweat.

The intraepidermal duct, called the acrosyringium, spirals through the epidermis in a distinctive corkscrew pattern. This helical architecture is visible histologically as multiple cross-sections of duct within the stratum spinosum and stratum corneum. The acrosyringium opens at the epidermal surface through a discrete pore that is separate from the follicular ostium—distinguishing eccrine from apocrine secretions.

Loading diagram...

Innervation and the Sweat Response

The eccrine gland receives its nerve supply from postganglionic sympathetic fibers that, atypically for the sympathetic nervous system, release acetylcholine rather than norepinephrine as their primary neurotransmitter. This cholinergic sympathetic innervation is one of only two such exceptions in the body (the other being the sympathetic vasodilator fibers to skeletal muscle). Clear cells express muscarinic M3 receptors that, upon acetylcholine binding, activate phospholipase C and raise intracellular calcium, triggering electrolyte secretion.

In addition to cholinergic stimulation, eccrine glands express α₁-adrenergic and β₂-adrenergic receptors, allowing catecholamines to modulate sweating under conditions of emotional stress. The contribution of adrenergic signaling to eccrine sweating is minor compared to cholinergic drive, but it explains the "cold sweat" that accompanies fear or anxiety—a predominantly palmoplantar response mediated by circulating epinephrine.

The central control of sweating resides in the hypothalamic sweat center, which monitors core body temperature and adjusts sympathetic outflow to maintain thermal homeostasis. When core temperature rises—whether from exercise, fever, or environmental heat—the hypothalamus increases cholinergic signaling to eccrine glands across the body, initiating the widespread sweating necessary for evaporative cooling. In contrast, emotional sweating is coordinated by limbic and cortical centers and is anatomically restricted to the palms, soles, axillae, and forehead.

Physiology of Sweat Production

Sweat is formed in a two-step process. In the secretory coil, clear cells actively pump sodium, potassium, and chloride into the glandular lumen, creating an osmotic gradient that draws water across aquaporin channels. The resulting primary secretion is nearly isotonic with plasma—approximately 140 mEq/L sodium and 100 mEq/L chloride.

As this primary secretion traverses the dermal duct, epithelial sodium channels (ENaC) and cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels reabsorb sodium and chloride, respectively, without accompanying water movement. Because the ductal epithelium is relatively water-impermeable, the final sweat delivered to the skin surface is markedly hypotonic—typically 10–40 mEq/L sodium at low secretion rates.

The degree of ductal reabsorption depends upon the rate of sweat production. At low flow rates, sweat spends more time in contact with the ductal epithelium, allowing greater electrolyte recovery and producing dilute sweat. At high flow rates—as during vigorous exercise in hot environments—sweat passes rapidly through the duct, limiting reabsorption and resulting in saltier secretions. This rate-dependent phenomenon explains why athletes exercising in heat can lose substantial quantities of sodium despite the kidney's homeostatic efforts.

At maximal stimulation, the human body can produce up to 3 liters of sweat per hour, a capacity that enables thermoregulation even under extreme thermal stress. Each liter of evaporated sweat dissipates approximately 580 kcal of heat energy—equivalent to half the metabolic rate of moderate exercise. Without eccrine sweating, humans would be confined to narrow thermal environments and incapable of the sustained physical activity that characterizes our species.

Composition of Eccrine Sweat

Eccrine sweat is a sterile, dilute fluid whose composition reflects both active secretion and passive diffusion from extracellular fluid. The major constituents include:

Electrolytes: Sodium chloride is the dominant solute, with potassium, bicarbonate, and calcium present in smaller quantities. The sodium content of sweat is diagnostically elevated in cystic fibrosis due to impaired CFTR-mediated chloride (and secondarily sodium) reabsorption.

Organic solutes: Lactate, urea, ammonia, and pyruvate are present in sweat at concentrations higher than in plasma, indicating active secretion by glandular cells. The lactate content of sweat produces the mildly acidic pH (4.5–6.5) that contributes to the skin's acid mantle and antimicrobial environment.

Antimicrobial peptides: Dermcidin is the signature antimicrobial peptide of eccrine sweat, produced constitutively by clear cells and activated by proteolytic cleavage upon secretion. Additional defense molecules include cathelicidins, β-defensins, and lactoferrin, which collectively provide broad-spectrum protection against bacteria, fungi, and viruses.

Drugs and toxins: The eccrine gland can excrete a variety of exogenous compounds, including antibiotics (ciprofloxacin, β-lactams), antifungals (fluconazole, griseofulvin), and chemotherapeutic agents (cyclophosphamide, cytarabine). This excretory function delivers certain systemic drugs to the stratum corneum—explaining how oral griseofulvin reaches dermatophyte-infected keratin—but can also cause cutaneous toxicity when irritant metabolites concentrate in sweat.

Clinical Correlations: Disorders of Eccrine Function

Hyperhidrosis

Hyperhidrosis refers to sweating in excess of thermoregulatory requirements. Primary hyperhidrosis is a common condition (affecting 1–3% of the population) characterized by excessive sweating of the axillae, palms, soles, and face without identifiable underlying cause. The disorder typically begins in childhood or adolescence, is bilateral and symmetric, and may have a familial component suggesting genetic predisposition.

The pathophysiology of primary hyperhidrosis is not fully understood, but evidence suggests hyperactivity of normal eccrine glands driven by exaggerated central sympathetic outflow rather than glandular hypertrophy. Patients with palmar hyperhidrosis often describe symptom exacerbation with emotional stress, consistent with limbic hyperactivation.

Treatment options for primary hyperhidrosis target different levels of the sweating pathway. Topical aluminum chloride occludes eccrine pores and precipitates in the acrosyringium, physically blocking sweat delivery. Iontophoresis introduces ions into the skin using electrical current, temporarily disrupting glandular function through uncertain mechanisms. Botulinum toxin injected intradermally blocks acetylcholine release at the neuroglandular junction, providing relief for 4–12 months per treatment. For refractory axillary hyperhidrosis, endoscopic thoracic sympathectomy can permanently ablate the T2–T4 sympathetic ganglia, though compensatory hyperhidrosis of the trunk and thighs is a common sequela.

Secondary hyperhidrosis differs from primary hyperhidrosis in that it occurs as a manifestation of underlying disease. Common causes include hyperthyroidism, pheochromocytoma, carcinoid syndrome, lymphoma, and menopausal estrogen withdrawal. The sweating of secondary hyperhidrosis is often generalized rather than localized and may occur at night (night sweats)—a pattern that should prompt investigation for occult malignancy or infection.

Hypohidrosis and Anhidrosis

Hypohidrosis (reduced sweating) and anhidrosis (absent sweating) may result from congenital absence of eccrine glands, acquired destruction of glandular structures, or pharmacologic blockade of sweat secretion.

Hypohidrotic ectodermal dysplasia (HED) is the prototypical congenital cause. This X-linked disorder, caused by mutations in EDA (encoding ectodysplasin-A), results in absent or severely reduced eccrine glands alongside sparse hair and abnormal dentition. Affected males are at risk of life-threatening hyperthermia in hot environments and require careful temperature regulation throughout life. The diagnosis may be suspected clinically based on the characteristic "old man" facies (frontal bossing, depressed nasal bridge, thin lips) and confirmed by genetic testing or skin biopsy showing absent eccrine structures.

Acquired hypohidrosis can result from infiltration or destruction of eccrine glands by inflammatory or neoplastic processes. Conditions such as scleroderma, graft-versus-host disease, and extensive burn scarring may obliterate functional eccrine units. Medications with anticholinergic effects—including antihistamines, tricyclic antidepressants, and bladder antispasmodics—can produce pharmacologic anhidrosis that resolves upon drug discontinuation.

Miliaria

Miliaria (sweat retention) occurs when occlusion of the eccrine duct results in rupture and extravasation of sweat into surrounding tissues. The condition is precipitated by excessive sweating, occlusive clothing or dressings, and bacterial colonization of the ductal epithelium.

The clinical presentation depends upon the level of ductal obstruction:

In miliaria crystallina, obstruction occurs within the stratum corneum, producing superficial, thin-walled vesicles containing clear fluid. The lesions are asymptomatic and resolve spontaneously with cooling.

In miliaria rubra ("prickly heat"), obstruction occurs at the intraepidermal level of the acrosyringium. Sweat leaking into the viable epidermis triggers an inflammatory response manifesting as pruritic erythematous papules and vesicles. Miliaria rubra is common in tropical climates and among hospitalized patients in warm, humid environments.

In miliaria profunda, obstruction extends to the dermal duct, with sweat extravasating into the dermis. The resultant lesions are flesh-colored papules that may be less symptomatic than miliaria rubra but carry greater risk of heat illness due to widespread functional anhidrosis.

Treatment of miliaria involves cooling the patient, removing occlusive materials, and allowing the obstructed ducts to clear. Topical corticosteroids may reduce inflammation in miliaria rubra, and antibacterial agents can address the staphylococcal colonization that often precedes ductal plugging.

Neutrophilic Eccrine Hidradenitis

Neutrophilic eccrine hidradenitis is an uncommon condition characterized by tender erythematous plaques, typically occurring in patients receiving chemotherapy. Histologically, the eccrine coils are surrounded and infiltrated by neutrophils without evidence of infection. The pathogenesis is thought to involve direct toxicity of chemotherapeutic agents—particularly cytarabine and anthracyclines—secreted into eccrine sweat, causing glandular epithelial damage and neutrophilic inflammation.

The condition is self-limited and resolves within days to weeks of completing chemotherapy. Similar histologic findings may occur in idiopathic settings or in association with HIV infection.

Summary

The eccrine sweat gland is a merocrine exocrine organ that develops independently of the pilosebaceous unit from surface ectoderm beginning at 3 months' gestation. The gland consists of a secretory coil containing clear cells, dark cells, and myoepithelial cells, and a two-layered duct that modifies sweat composition through sodium and chloride reabsorption. Eccrine glands are innervated by cholinergic sympathetic fibers and regulated by the hypothalamic sweat center for thermoregulation and by limbic/cortical centers for emotional sweating. Sweat is a hypotonic fluid containing electrolytes, organic acids, and antimicrobial peptides including dermcidin. Clinical disorders include hyperhidrosis (treated with aluminum chloride, iontophoresis, botulinum toxin, or sympathectomy), hypohidrosis/anhidrosis (including hypohidrotic ectodermal dysplasia from EDA mutations), miliaria (crystallina, rubra, profunda), and neutrophilic eccrine hidradenitis.

This section establishes the anatomical and physiological framework for understanding eccrine gland disorders discussed in later clinical chapters.